Key challenges when dealing with vaccine innovation, technology and partnerships in emerging markets

I recently posed this question on LinkedIn, where industry professionals had a chance to discuss and answer the question.  Take a look at the discussion that took place below.  Do you have any challenges that didn't make this discussion?  Comment below and share.  Alternatively, join our Vaccine Nation LinkedIn group for similar conversations. The conversation took place between: Andrew Lees, …